6
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
video
The Evolution of ESG and Asset Management
Investors today increasingly consider issues such as climate change, diversity, community engageme
nt, and overall sustainability in their approach to managing risk and maximizing impact in their portfolios.
+ Read More
article
Tech Regulation Digest: Big Tech, HIPAA, and the GDPR: Balancing Patient Privacy and Data Sharing in Health Tech
Overview
As Big Tech companies face continued scrutiny over their handling of personal health infor
mation, the limitations of US health privacy regulation in a digital age are becoming more evident.
+ Read More
article
Reaching for Resilience in a More Uncertain Investment Environment
The world is fragmenting., Investors will reach for resilience in their portfolio construction.
, Fi
ve Macroeconomic Implications
First, higher spending in many areas, including defense, health care, energy and food security, more resilient supply chains, and climate risk mitigation and adaptation, may well support aggregate demand.
+ Read More
article
FasterCures Quarterly Update—January 2024
In This Newsletter
New FasterCures Team Members
Recent FasterCures Publications
Events and Convenin
gs Recap
+ Read More
article
MI Philanthropy December 2023 Newsletter
In This Issue:
Highlights
Program Updates
Reports and Resources
MI Philanthropy and Our Partners in
the News
+ Read More